Back to Search
Start Over
Gene on, gene off: Chroma Medicine turns lights on with $125M to control gene expression with ex-Editas, Regeneron leaders.
- Source :
- FierceBiotech; 11/17/2021, pN.PAG-N.PAG, 1p
- Publication Year :
- 2021
-
Abstract
- Chroma Medicine emerges with $125 million to bankroll development of epigenetic editing to create therapeutics that control gene expression. The biotech is led by former Editas Medicine and Regeneron leaders who will lead Chroma's efforts at silencing and activating genes across a range of therapeutic areas. [ABSTRACT FROM AUTHOR]
- Subjects :
- GENE expression
GENE silencing
GENES
EPIGENETICS
VENTURE capital
Subjects
Details
- Language :
- English
- Database :
- Complementary Index
- Journal :
- FierceBiotech
- Publication Type :
- Periodical
- Accession number :
- 153628364